De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer

Authors: Alex K. Bryant, K. Nathan Sankar, Lili Zhao, Garth W. Strohbehn, David J. Elliott, Drew Moghanaki, Michael J. Kelley, Nithya Ramnath, Michael D. Green - European Journal of Cancer 2022 cited by 24